House
May 27, 2020To provide for quality assurance of COVID-19 reimbursements and reporting.
Summary
Official
This bill (1) establishes documentation requirements for testing, treatment, and reporting related to COVID-19 (i.e., coronavirus disease 2019); and (2) makes it unlawful to knowingly report a false diagnosis of COVID-19. To receive a federal reimbursement for the cost of a COVID-19 diagnostic test or treatment, the request for reimbursement must document that the administered COVID-19 test...
Bill Progress
Bill has been introduced and assigned a number
Introduced(5/27/20)
Committee
Passed
House
Passed
Senate
President
Law
Sponsor
BP
Mr. Posey
(R) FL – 8
Topics
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 27, 2020